MX9705757A - Mutantes (eif-5a) del factor eucariotico 5a de iniciacion. - Google Patents

Mutantes (eif-5a) del factor eucariotico 5a de iniciacion.

Info

Publication number
MX9705757A
MX9705757A MX9705757A MX9705757A MX9705757A MX 9705757 A MX9705757 A MX 9705757A MX 9705757 A MX9705757 A MX 9705757A MX 9705757 A MX9705757 A MX 9705757A MX 9705757 A MX9705757 A MX 9705757A
Authority
MX
Mexico
Prior art keywords
eif
mutants
initiation factor
eukaryotic initiation
rev function
Prior art date
Application number
MX9705757A
Other languages
English (en)
Other versions
MXPA97005757A (es
Inventor
Joachim Hauber
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9502771.0A external-priority patent/GB9502771D0/en
Priority claimed from GBGB9513505.9A external-priority patent/GB9513505D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX9705757A publication Critical patent/MX9705757A/es
Publication of MXPA97005757A publication Critical patent/MXPA97005757A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describen las proteínas mutantes elF-5A las cuales están normalmente desprovistas de actividad eIF-5A sustancial, y las cuales inhiben la funcion Rev, y de este modo poseen un fenotipo inhibitorio con respecto a la funcion Rev, y los genes o secuencias de ADN o de ADNc que codifican para los mismos.
MXPA/A/1997/005757A 1995-02-13 1997-07-30 Mutantes (eif-5a) del factor eucariotico 5a de iniciacion MXPA97005757A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9502771.0A GB9502771D0 (en) 1995-02-13 1995-02-13 Organic compounds
GB9513505.9 1995-07-03
GBGB9513505.9A GB9513505D0 (en) 1995-07-03 1995-07-03 Organic compounds
GB9502771.0 1995-07-03

Publications (2)

Publication Number Publication Date
MX9705757A true MX9705757A (es) 1998-07-31
MXPA97005757A MXPA97005757A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
CZ255397A3 (cs) 1998-02-18
IL117113A0 (en) 1996-06-18
CA2210538A1 (en) 1996-08-22
CN1173897A (zh) 1998-02-18
NO973679L (no) 1997-10-13
FI972763A (fi) 1997-10-10
HUP9801681A3 (en) 2000-10-30
PL321239A1 (en) 1997-11-24
BR9606951A (pt) 1997-10-28
EP0811060A1 (en) 1997-12-10
FI972763A0 (fi) 1997-06-26
HUP9801681A2 (hu) 1998-10-28
WO1996025492A1 (en) 1996-08-22
KR19980702160A (ko) 1998-07-15
JPH10509327A (ja) 1998-09-14
AU4665196A (en) 1996-09-04
NO973679D0 (no) 1997-08-11
SK109997A3 (en) 1998-04-08

Similar Documents

Publication Publication Date Title
NZ335945A (en) Presenilin proteins and genetic sequences that are related to Alzheimer's disease
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
SG141233A1 (en) Control of gene expression
AU6724194A (en) Nucleotide sequences for the control of the expression of dna sequences in a cellular host
UA13321A (uk) Спосіб експресії мітогеhhого білка еhдотеліальhих клітиh людиhи
MX9804263A (es) Expresion de genes incrementada por intensificador en plantas.
CA2079454A1 (en) Steroid 5.alpha.-reductases
GR3030876T3 (en) VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE
AU3802595A (en) Tripeptidyl aminopeptidase
AU6724794A (en) GRB3-3 gene, its variants and their uses
NO973679L (no) Eukaryotisk initieringsfaktor 5A (eIF-5A) mutanter
WO2002086098A3 (en) A lac operator-repressor system
AU8148398A (en) Nucleotide sequences of genes encoding sink proteins and uses thereof for improving the nutritional quality of feeds
ZA97835B (en) Purified sr-p70 protein
NZ326596A (en) Isolated vertebrate signalin gene peptide and use in intracellular signal transduction pathways mediated by TGF beta
CA2260765A1 (en) Purified proteins, recombinant dna sequences and processes for controlling the ripening of coffee plants
DE69526087T2 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
MXPA97005757A (es) Mutantes (eif-5a) del factor eucariotico 5a de iniciacion
CA2182116A1 (en) Cd 69 transcriptional regulatory elements
WO1994025606A3 (de) Rekombinante alanin racemase und gapdh aus tolypocladium niveum
ATE386114T1 (de) Gene, die für lymphocyte spezifischen interferon- regulationsfaktor (lsirf) polypeptide kodiert
EP0594710A4 (en) TYROSINE-KINASE.
MY132368A (en) Malathion carboxylesterase
WO2002033104A3 (en) Antibiotic-based gene regulation system